# RiskMitigation: __Use of specific medicines__ (PBN__Mitigation_1555)

## Property: has_MitigationTechnology

* [anti-bacterial](../Technology/PBN__Technology_3917)
* [antimalarial](../Technology/PBN__Technology_3918)
* [antiviral](../Technology/PBN__Technology_3919)
* [protease inhibitors](../Technology/PBN__Technology_3920)
* [corticosteroids](../Technology/PBN__Technology_3921)

## Property: has_MitigationSource

* [paital_nurture_2020](../Article/PBN__Article_44)

## Property: has_MitigationPrinciple

Repurposing existing medicines such as anti-bacterial, antimalarial, and antiviral drugs, as well as protease inhibitors and corticosteroids, for the treatment of COVID-19. These medicines are used to reduce the severity of symptoms and prevent complications in infected individuals.

